-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RfrQKHyaNEjc6jYvVNIHHFT20kxUXGF7O2k1O4hDHvugcIekUvoGTCjOqNunrCbD FbHkCK2qPHt6luE/VV/VqQ== 0001200876-03-000045.txt : 20030806 0001200876-03-000045.hdr.sgml : 20030806 20030806092232 ACCESSION NUMBER: 0001200876-03-000045 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20030806 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ZAPPALA JOSEPH CENTRAL INDEX KEY: 0001213648 FILING VALUES: FORM TYPE: SC 13G MAIL ADDRESS: STREET 1: 7227 CLINT MOORE ROAD CITY: BOCA RATON STATE: FL ZIP: 33496 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INNOVATIVE COMPANIES INC CENTRAL INDEX KEY: 0001098315 STANDARD INDUSTRIAL CLASSIFICATION: DAIRY PRODUCTS [2020] IRS NUMBER: 592600232 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-78678 FILM NUMBER: 03825116 BUSINESS ADDRESS: STREET 1: 6950 BRYAN DAIRY RD CITY: LARGO STATE: FL ZIP: 33777 BUSINESS PHONE: 7275448866 MAIL ADDRESS: STREET 1: 6950 BRYAN DAIRY RD CITY: LARGO STATE: FL ZIP: 33777 FORMER COMPANY: FORMER CONFORMED NAME: INNOVATIVE COS INC DATE OF NAME CHANGE: 20030627 FORMER COMPANY: FORMER CONFORMED NAME: GO2PHARMACY COM INC DATE OF NAME CHANGE: 20000512 FORMER COMPANY: FORMER CONFORMED NAME: INNOVATIVE HEALTH PRODUCTS INC DATE OF NAME CHANGE: 19991103 SC 13G 1 zappala13g.htm ZAPP13G 13G

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

 

Innovative Companies, Inc.

_____________________

(Name of Issuer)

 

Common Stock

________________________

(Title of Class of Securities)

 

380193 10 2

____________________________

(CUSIP Number)

 

December 31, 2002

________________________________

(Date of Event Which Requires Filing of this Statement)

 

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[  ]           Rule 13d-1(b)

[  ]           Rule 13d-1(c)

[X]           Rule 13d-1(d)

 

 


 

CUSIP No.   380193 10 2                                       

1

NAME OF REPORTING PERSON

  Joseph Zappala

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*         

 (a) [  ] 

 (b) [  ]

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

     U.S.A.

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5

SOLE VOTING POWER

 

1,350,167

6

SHARED VOTING POWER

435,000

7

SOLE DISPOSITIVE POWER

 

1,350,167

8

SHARED DISPOSITIVE POWER

435,000

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  

1,785,167

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

             [  ]

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

25.4% 

12

TYPE OF REPORTING PERSON*     IN

*SEE INSTRUCTIONS BEFORE FILLING OUT.
 

CUSIP No.   380193 10 2                                       

1

NAME OF REPORTING PERSON

  Isabel Zappala

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*         

 (a) [  ] 

 (b) [  ]

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

     U.S.A.

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5

SOLE VOTING POWER

385,000

6

SHARED VOTING POWER

1,400,167

 

7

SOLE DISPOSITIVE POWER

385,000

 

8

SHARED DISPOSITIVE POWER

1,400,167

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  

1,785,167

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

             [  ]

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

25.4% 

12

TYPE OF REPORTING PERSON*     IN

*SEE INSTRUCTIONS BEFORE FILLING OUT.


CUSIP No.   380193 10 2                                      

Item 1.    (a)           Name of Issuer:       Innovative Companies, Inc. f/k/a Go2Pharmacy, Inc.

Item 1.    (b)           Address of Issuer's Principal Executive Offices:

6950 Bryan Dairy Road, Largo, Florida 33777

Item 2.    (a)           Name of Person Filing:    Joseph Zappala

                                                                     Isabel Zappala

 

Item 2.    (b)           Address of Principal Business Office or if None, Residence:

 

7227 Clint Moore Road

Boca Raton, Florida 33496

Item 2.    (c)           Citizenship:   USA

Item 2.    (d)           Title of Class of Securities:    Common Stock, $.01 par value

Item 2.    (e)           Cusip Number:            380193 10 2

Item 3.    Statements filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the Person filing is a:   N/A

(a)

[  ]

Broker or dealer registered under Section 15 of the Exchange Act.

(b)

[  ]

Bank as defined in Section 3(a)(6) of the Exchange Act.

(c)

[  ]

Insurance company as defined in Section 3(a)(19) of the Exchange Act.

(d)

[  ]

Investment company registered under Section 8 of the Investment Company Act.

(e)

[  ]

An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

(f)

[  ]

An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

(g)

[  ]

A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

(h)

[  ]

a savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

(i)

[  ]

A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;

(j)

[  ]

Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

 

If this statement is filed pursuant to Rule 13d-1(c), check this box.           [  ]

 


CUSIP No.   380193 10 2                                      

Item 4.    Ownership

        (a)           Amount Beneficially Owned (describe):  Of the 1,785,167 shares reported pursuant to this Schedule 13G; 1,337,500 shares are owned directly by Joseph Zappala; 385,000 shares are owned by Isabel Zappala, 50,000 shares are owned by their minor child, and 12,667 shares are subject to currently exercisable options held by Joseph Zappala.  Both Joseph Zappala and Isabel Zappala disclaim beneficial ownership of all the shares they do not directly hold.   

[any options exercisable within 60 days of the calendar year end?].

       (b)           Percent of Class:  25.4%, based on the 7,025,000 outstanding shares on November 16, 2002, as reported in the Issuer's 10-Q filed for the quarter ending September 30, 2002.

      (c)           Number of shares as to which such person has sole or shared power to dispose or vote the shares: See corresponding cover sheet.

Item 5.    Ownership of Five Percent or Less of a Class:    n/a

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. 

Item 6.    Ownership of More than Five Percent on Behalf of Another Person:  n/a

Item 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:    n/a

Item 8.    Identification and Classification of Members of the Group:  n/a

Item 9.    Notice of Dissolution of Group:    n/a


CUSIP No. 380193 10 2                                        

Item. 10. Certification (see Rule 13d-1(b) and (c)):

Exhibits     Exhibit 1 Joint Filing Agreement, dated July 3, 2003 between Joseph Zappala and Isabel Zappala.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated:  July 3, 2003                               

                                                                      /s/Joseph Zappala_______________

                                                                          Joseph Zappala

 

                                                                       /s/Isabel Zappala_______________

                                                                           Isabel Zappala

EXHIBIT 1

JOINT FILING AGREEMENT

    This Joint Filing Agreement (the "Agreement") dated July 3, 2003, by and among  Joseph Zappala and Isabel Zappala, husband and wife (collectively, the "Reporting Persons").

    The Reporting Persons agree to jointly prepare and file with the United States Securities and Exchange Commission (the "SEC") an amendment to Schedule 13G and any attachments thereto reporting each of the Reporting Persons' beneficial ownership of shares of the common stock of Go2Pharmacy, Inc. n/k/a Innovative Companies, Inc., a Florida corporation ("Issuer") and affirm that such amendment and any attachments thereto are being filed on behalf of each of the Reporting Persons.

    This  Agreement shall remain in full force and effect  until the Reporting Persons are no longer required to file any Schedule 13Gs  with respect  to the Reporting Persons'  holdings  of  and transactions in securities issued by Issuer.

    IN WITNESS WHEREOF, the parties to this Agreement have executed this
Agreement as of the date first written above                             

                                                              

                                                                                      /s/Joseph Zappala_________

                                                                                       Joseph Zappala

 

                                                                                         

                                                                                       /s/Isabel Zappala_________

                                                                                       Isabel Zappala

 

EX-1 3 exzappala13g.htm EX1 13G

EXHIBIT 1

JOINT FILING AGREEMENT

    This Joint Filing Agreement (the "Agreement") dated July 3, 2003, by and among  Joseph Zappala and Isabel Zappala, husband and wife (collectively, the "Reporting Persons").

    The Reporting Persons agree to jointly prepare and file with the United States Securities and Exchange Commission (the "SEC") an amendment to Schedule 13G and any attachments thereto reporting each of the Reporting Persons' beneficial ownership of shares of the common stock of Go2Pharmacy, Inc. n/k/a Innovative Companies, Inc., a Florida corporation ("Issuer") and affirm that such amendment and any attachments thereto are being filed on behalf of each of the Reporting Persons.

    This  Agreement shall remain in full force and effect  until the Reporting Persons are no longer required to file any Schedule 13Gs  with respect  to the Reporting Persons'  holdings  of  and transactions in securities issued by Issuer.

    IN WITNESS WHEREOF, the parties to this Agreement have executed this
Agreement as of the date first written above                             

                                                              

                                                                   /s/Joseph Zappala_________

                                                                   Joseph Zappala

 

                                                                                         

                                                                    /s/Isabel Zappala_________

                                                                     Isabel Zappala

 

-----END PRIVACY-ENHANCED MESSAGE-----